2 ML diazepam 5 MG/ML Prefilled Syringe — RxCUI 2120550
RxNorm drug concept · Semantic clinical drug
RxCUI 2120550
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2120550
Official name2 ML diazepam 5 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdiazepam 10 MG per 2 ML Prefilled Syringe; diazePAM 10 MG in 2 ML Prefilled Syringe
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)8,752 prescriptions · 29 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Diazepam Rectal: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- No — this medication is specifically for seizure clusters, which are episodes of repeated seizures that are different from your family member's (or your own) usual seizure pattern....
- When exactly should I give the diazepam rectal gel — as soon as any seizure starts?
- Yes, the prescriber may authorize a second dose, but there are rules: it can only be given 4 to 12 hours after the first dose, and only if your prescriber has said to do so in your...
- Can I give a second dose if the seizures don't stop after the first?
🕸️ Concept Web — How 2 ML diazepam 5 MG/ML Prefilled Syringe Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
2 ML diazepam 5 MG/ML Prefilled Syringe
RxCUI 2120550 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Diazepam
3322IN
-
Diazepam
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Diazepam Prefilled Syringe
2120549SCDF -
Diazepam Injectable Product
1155859SCDG -
Prefilled Syringe
721656DF -
Injectable Product
1151126DFG
-
Diazepam Prefilled Syringe
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Diazepam 5 MG/ML
315799SCDC
-
Diazepam 5 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Diazepam 5 MG/ML
SCDC · 315799 -
Diazepam Prefilled Syringe
SCDF · 2120549 -
Diazepam Injectable Product
SCDG · 1155859
📦 FDA Products & Package NDCs
12 products · 12 package NDCs
12 package NDCs map to RxCUI 2120550 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00404-9769-02 | 1 SYRINGE in 1 BAG (0404-9769-02) / 2 mL in 1 SYRINGE | DIAZEPAM | Henry Schein, Inc. | 2025-11-18 |
| 00641-6244-10 | 10 SYRINGE in 1 CARTON (0641-6244-10) / 2 mL in 1 SYRINGE | Diazepam | Hikma Pharmaceuticals USA Inc. | 2021-05-18 |
| 25021-0618-72 | 10 SYRINGE in 1 CARTON (25021-618-72) / 2 mL in 1 SYRINGE | Diazepam | Sagent Pharmaceuticals | 2026-02-15 |
| 43598-0106-10 | 10 SYRINGE, GLASS in 1 CARTON (43598-106-10) / 2 mL in 1 SY... | Diazepam | Dr. Reddy's Laboratories Inc | 2024-08-07 |
| 43598-0106-58 | 10 SYRINGE, GLASS in 1 CARTON (43598-106-58) / 2 mL in 1 SY... | Diazepam | Dr. Reddy's Laboratories Inc | 2026-05-11 |
| 46708-0811-20 | 10 SYRINGE, GLASS in 1 CARTON (46708-811-20) / 2 mL in 1 SY... | Diazepam | Alembic Pharmaceuticals Limited | 2024-04-25 |
| 62332-0811-20 | 10 SYRINGE, GLASS in 1 CARTON (62332-811-20) / 2 mL in 1 SY... | Diazepam | Alembic Pharmaceuticals Inc. | 2024-04-25 |
| 69339-0136-34 | 10 SYRINGE, GLASS in 1 CARTON (69339-136-34) / 2 mL in 1 SY... | Diazepam | Natco Pharma USA LLC | 2021-04-01 |
| 69339-0136-97 | 10 SYRINGE, GLASS in 1 CARTON (69339-136-97) / 2 mL in 1 SY... | Diazepam | Natco Pharma USA LLC | 2025-05-01 |
| 70518-2358-01 | 10 SYRINGE, GLASS in 1 CARTON (70518-2358-1) / 2 mL in 1 SY... | Diazepam | REMEDYREPACK INC. | 2021-06-18 |
| 72572-0140-02 | 10 SYRINGE, GLASS in 1 CARTON (72572-140-02) / 2 mL in 1 SY... | Diazepam | Civica, Inc. | 2019-12-01 |
| 76045-0204-20 | 24 SYRINGE, GLASS in 1 CARTON (76045-204-20) / 2 mL in 1 SY... | Diazepam | Fresenius Kabi USA, LLC | 2022-11-10 |
Observed labelers:
Dr. Reddy's Laboratories Inc (2) ·
Natco Pharma USA LLC (2) ·
Alembic Pharmaceuticals Inc. (1) ·
Alembic Pharmaceuticals Limited (1) ·
Civica, Inc. (1) ·
Fresenius Kabi USA, LLC (1)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J3360 | Diazepam injection | 8 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.